Advertisement
Tips for increasing patient adherence to treatment plans include patient engagement and addressing barriers to adherence

Tips Presented for Encouraging Treatment Adherence

0
Broad approach recommended, which includes patient engagement and addressing barriers
Seafood consumption is associated with increased brain levels of mercury

Mercury From Seafood Not Tied to Brain Neuropathology

0
Significant link for seafood consumption with less Alzheimer's disease pathology in APOE ε4 carriers

January 2016 Briefing – Neurology

0
Here are what the editors at HealthDay consider to be the most important developments in Neurology for January 2016. This roundup includes the latest...
Some clinical departments tend to undertreat when prescribing statins

Many Physicians Show Tendency to Undertreat With Statins

0
Target levels more likely to be achieved in departments that prescribe more statins
Comorbidities in Parkinson's disease patients impact physicians' fitness-to-drive recommendations

Comorbidity Affects Fitness-to-Drive Recs in Parkinson’s Disease

0
Physicians consider comorbidities, but on-road assessors may not
An open-label

Proton Radiotherapy May Be New Option for Peds Brain Tumor

0
Acceptable toxicity, similar survival as conventional radiotherapy for childhood medulloblastoma
Mobile telephone text messaging may be a promising new way to improve adherence to medications for chronic diseases

Mobile Texts May Up Adherence to Meds for Chronic Illness

0
Meta-analysis shows mobile phone text reminders double the odds of medication adherence
Taking prescription opioids doesn't improve movement or reduce disability for patients with neuropathic pain

Opioids Don’t Ease Disability in Neuropathic Pain

0
Medications aren't useful in restoring motion, researchers say
Demand for medical office space for ambulatory care is at a high point and looks likely to continue increasing

Demand for Medical Office Space High and Increasing

0
Vacancy rate for medical office buildings 9.5 percent in third quarter of 2015; lowest since 2007
For patients with John Cunningham virus (JCV)

Tysabri Impacts Seroconversion in John Cunningham Virus

0
Over 14.8 months, natalizumab treatment linked to 15.9 percent increase of value in JCV+ patients